CompaniesBiomerix

Biomerix

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

2

As Collaborator

3

Total Enrollment

2,956

By Phase

PHASE4: 2NA: 2

By Status

COMPLETED: 2UNKNOWN: 2RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT00261014
Hover over trial bars to see details

Recent Trials

NCT05979545Collaborator
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
PHASE4Recruiting
1,900 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2026
NCT04189874Collaborator
Stool Testing With Molecular Assay to Minimize Contact Precautions
NACompleted
156 participants
Started: Dec 18, 2019 · Completed: Feb 12, 2021
NCT03439111Lead Sponsor
Standardized Lycium Chinense Fruit Extract Enhances Attention and Cognitive Function in Healthy Young People
NACompleted
75 participants
Started: Nov 1, 2011 · Completed: Apr 30, 2013
NCT00924755Lead Sponsor
Study of Surgical Mesh for Inguinal Hernia Repair
PHASE4Unknown
25 participants
Started: Jun 30, 2009 · Completed: Nov 30, 2010
NCT00261014Collaborator
Understanding Risk Factors Involved in Developing a Second Blood Clot.
N/AUnknown
800 participants
Started: Oct 31, 2002 · Completed: Mar 31, 2016